This MedTech NAVIGATOR Report provides a landscape assessment of the innovations under development in the area of respiratory disease.
The report will be relevant to SMEs based in the UK and to those based further afield.
Respiratory disease affects approximately 20% of people and is the third biggest cause of death in England.
Lung cancer, pneumonia and chronic obstructive pulmonary disease (COPD) are the biggest causes of death.
Respiratory disease is identified as a clinical priority in the NHS Long Term Plan.
It is estimated that 12.7 million people in the UK are living with respiratory disease and lung conditions are estimated to cost around £9.9 billion each year.
Key findings of the report:
A new wave of digital ‘smart’ inhalers are coming onto the market. A major challenge will be integrating these into the current NHS pathway.
We provide an up to date analysis of what respiratory disease innovation have been funded by Innovate UK, SBRI and NIHR i4i awards.
